Selectra SICAV Investments – J. LAMARCK PHARMA

Name: J.LAMARCK PHARMA

Inception: 30/06/2015

Inv. Manager: SELECTRA Management Company S.A.

Inv. Advisor: J.LAMARCK S.p.A.

Strategy: The focus is on mature top tier pharmaceutical companies and companies with interesting pipeline of products in development in a single or numerous markets. The followed investment policy will enable the Sub-Fund to increase overall return by active stock selection of companies, offering the most promising technology platform.

Geographical Area: Worldwide

Asset Class: Equity Fund

Info: www.lamarcksicav.eu